Evidence map›Paper›PMID 18985344›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2009

Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.

Reiko Kameyama, Yuka Yamamoto, Kunihiko Izuishi, Ryusuke Takebayashi, Masanobu Hagiike, Makiko Murota, Masato Kaji, Reiji Haba, Yoshihiro Nishiyama

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Comparison ofTomography (Ann Arbor, Mich.) · 2022
    Article
  4. Imaging of Gastric Carcinomatosis.Journal of clinical medicine · 2021
    Article
  5. Article
  6. Imaging peritoneal metastasis of gastric cancer withThe British journal of radiology · 2018
    Article
  7. Preoperative staging of nodal status in gastric cancer.Translational gastroenterology and hepatology · 2017
    Review
  8. Evaluation ofEJNMMI research · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2013
    Article
  17. Article
  18. (18)F-FLT PET/CT in Patients with Gastric Carcinoma.Gastroenterology research and practice · 2013
    Article
  19. Review
  20. Gastric cancer: surgery in 2011.Langenbeck's archives of surgery · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Reiko KameyamaDepartment of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan. reikok@med.kagawa-u.ac.jp.
Yuka Yamamoto
Kunihiko Izuishi
Ryusuke Takebayashi
Masanobu Hagiike
Makiko Murota
Masato Kaji
Reiji Haba
Yoshihiro Nishiyama
Kagawa University · JPKagawa University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe prospectively investigated the feasibility of 3'-deoxy-3'-(18)F-fluorothymidine (FLT) positron emission tomography (PET) for the detection of gastric cancer, in comparison with 2-deoxy-2-(18)F-fluoro-D-glucose (FDG) PET, and determined the degree of correlation between the two radiotracers and proliferative activity as indicated by Ki-67 index.

methodsA total of 21 patients with newly diagnosed advanced gastric cancer were examined with FLT PET and FDG PET. Tumour lesions were identified as areas of focally increased uptake, exceeding that of surrounding normal tissue. For semiquantitative analysis, the maximal standardized uptake value (SUV) was calculated.

resultsFor detection of advanced gastric cancer, the sensitivities of FLT PET and FDG PET were 95.2% and 95.0%, respectively. The mean (+/-SD) SUV for FLT (7.0 +/- 3.3) was significantly lower than that for FDG (9.4 +/- 6.3 p < 0.05). The mean FLT SUV and FDG SUV in nonintestinal tumours were higher than in intestinal tumours, although the difference was not statistically significant. The mean (+/-SD) FLT SUV in poorly differentiated tumours (8.5 +/- 3.5) was significantly higher than that in well and moderately differentiated tumours (5.3 +/- 2.1; p < 0.04). The mean FDG SUV in poorly differentiated tumours was higher than in well and moderately differentiated tumours, although the difference was not statistically significant. There was no significant correlation between Ki-67 index and either FLT SUV or FDG SUV.

conclusionFLT PET showed as high a sensitivity as FDG PET for the detection of gastric cancer, although uptake of FLT in gastric cancer was significantly lower than that of FDG.

Indexed as

DideoxynucleosidesFluorine RadioisotopesFluorodeoxyglucose F18RadiopharmaceuticalsAdenocarcinomaAdultAgedAged, 80 and overCell ProliferationFemaleHumansImmunohistochemistryKi-67 AntigenMaleMiddle AgedPositron-Emission TomographyalovudineDideoxynucleosidesFluorine RadioisotopesFluorodeoxyglucose F18Ki-67 AntigenRadiopharmaceuticals

Identifiers

PMID18985344
OpenAlexW1978171103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.